BioCentury
ARTICLE | Distillery Therapeutics

Targeting hexokinase 2 to enhance intratumoral drug delivery

December 3, 2021 5:34 PM UTC

DISEASE CATEGORY: Cancer

INDICATION: Non-small cell lung cancer (NSCLC); hepatocellular carcinoma...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Sun Yat-sen University

BCIQ Target Profiles

Hexokinase 2 (HK2)